Cover Image

The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Amalia M. Issa
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Clinical Pharmacology in Drug Development
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

From Bench to Bedside and Beyond: Shaping the Future of Early‐Phase Clinical Pharmacology at CPDD
by: Amalia M. Issa
Published: (2025)

Editorial: Early Phase Innovation—Adapting to the New Age of Accelerated Drug Approvals
by: Amalia M. Issa
Published: (2025)

What Makes an Early‐Phase Study Worth Publishing? A View from the Editor's Desk
by: Amalia M. Issa
Published: (2026)

From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities
by: Amalia M. Issa
Published: (2026)

Are We Overstudying Biosimilars? Re‐Centering Clinical Pharmacology in the Demonstration of Similarity
by: Amalia M. Issa
Published: (2026)

A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers
by: Vipul K. Gupta, et al.
Published: (2026)

Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
by: Hyung Soon Lim, et al.
Published: (2024)

Physiologically Based Pharmacokinetic Modeling to Evaluate Drug‐Drug Interactions of Tacrolimus With Ritonavir, a CYP3A Irreversible Inhibitor: Applications for Dosing Optimization in Transplant Patients
by: Yanjun Jiang, et al.
Published: (2025)

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants
by: Andrea Francesco Daniele Di Stefano, et al.
Published: (2025)

Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach
by: Michiel de Vries, et al.
Published: (2024)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double‐Blind, Placebo‐Controlled Study
by: Jonathan Williams, et al.
Published: (2025)

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
by: Eugenio Mercuri, et al.
Published: (2026)

Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase
by: Akmal Zubair, et al.
Published: (2025)

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
by: Caroline A. Lee, et al.
Published: (2024)

Correction to “Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsenin Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses”
Published: (2025)

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Bexicaserin in Healthy Participants: A First‐in‐Human Randomized, Double‐Blind, Placebo‐Controlled Single Ascending Dose Escalation Phase 1 Study
by: Rosa Chan, et al.
Published: (2025)

Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single‐Dose Phase 1 Study
by: Aravind Mittur, et al.
Published: (2026)

Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants
by: Jianke Li, et al.
Published: (2024)

Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers
by: Bruce L Daugherty, et al.
Published: (2026)

A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy
by: Randolph P. Matthews, et al.
Published: (2024)

Concentration–QTc Modeling to Support Clinical Development of Fezolinetant
by: Jace C. Nielsen, et al.
Published: (2025)

Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
by: Junyu Xu, et al.
Published: (2024)

A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants
by: Rajinder Bhardwaj, et al.
Published: (2024)

A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk
by: Chenna Keshava Reddy Sannala, et al.
Published: (2024)

A Phase 1, Open‐Label, Single‐Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR Inhibitor
by: Wei Zhu, et al.
Published: (2026)

Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study
by: Chenning Zhang, et al.
Published: (2024)

Pharmacokinetics of Depemokimab Delivered by Safety Syringe Device or Autoinjector in Healthy Adults: A Phase 1, Single‐Dose Study
by: Stein Schalkwijk, et al.
Published: (2025)

Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study
by: Ramesh Boinpally, et al.
Published: (2024)

Bioequivalence and Safety Assessment of 2 Formulations of Low‐Dose Metformin Hydrochloride under Fasting Conditions in Healthy Chinese Participants: A Randomized Phase 1 Clinical Trial
by: Ming‐Li Sun, et al.
Published: (2024)

Comparative Bioequivalence Study of 2 Clevidipine Formulations in Healthy Chinese participants: A Single‐Dose, 2‐Period Crossover Trial
by: Zhuo Chen, et al.
Published: (2025)

Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers
by: Chuei Wuei Leong, et al.
Published: (2024)

Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
by: Shichang Miao, et al.
Published: (2024)

Comparative Bioequivalence Study of 2 Fixed‐Dose Combinations of Vildagliptin and Metformin at a Tablet Strength of 50/1000 mg in Moroccan Volunteers
by: Salma Lazrak, et al.
Published: (2025)

First‐in‐Human Study of Merotocin, a Short‐Acting Peptidic Oxytocin Receptor Agonist for Lactation Support
by: Yu Bagger, et al.
Published: (2025)

A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer
by: Michael J. Hanley, et al.
Published: (2025)

Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs
by: Kelong Han, et al.
Published: (2025)

Bioequivalence and Food Effect Assessment of Eltrombopag Olamine Tablets in Healthy Chinese Subjects: An Open, Randomized, Single‐Dose, and Two‐Period Crossover Study
by: Jingyan Wang, et al.
Published: (2024)

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double‐Blind, Phase 1 Studies
by: Naihan Chen, et al.
Published: (2025)

Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections
by: Kelong Han, et al.
Published: (2025)

Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants
by: Alessandra Cipriano, et al.
Published: (2024)